IQWiG: Tafinlar/Mekinist Benefit 'Considerable' In Men With Melanoma, But Still Better In Women
This article was originally published in Scrip
Executive Summary
Germany's HTA body IQWiG has declared that there is "an indication of a considerable added benefit for men" of the combination of Novartis' Tafinlar and Mekinist (dabrafenib and trametinib).